CHANGSHA, May 14 (Xinhua) -- Police had finished the investigation on the suspected bribery case of GlaxoSmithKline(GSK) China and handed it over to prosecutors, local police said here Wednesday.
After ten months of investigation, police found that William Mark Reilly, a British national and executive of GSK China, had ordered his subordinates to commit bribery, said the police of Changsha, capital of central China's Hunan Province, in a statement.
Reilly allegedly pressed his sales teams to bribe hospitals, doctors and health institutions through various means and gained an illegal revenue worth of billions.
He and two other executives, Zhang Guowei and Zhao Hongyan, were also suspected of bribing officials with the industry and commerce departments of Beijing and Shanghai.
(To stay up to date with the latest China news, follow XHNews on Twitter at http://www.twitter.com/XHNews and Xinhua News Agency on Facebook at http://www.facebook.com/XinhuaNewsAgency.)
Xinhua Insight: Police reveal details of GSK China's alleged violations
BEIJING, July 26 (Xinhua) -- The Chinese police on Thursday revealed details of GlaxoSmithKline (GSK) China's alleged bribery and tax-related violations that pushed up drug prices and disrupted market order.
After the Ministry of Public Security (MPS) announced on July 11 that some employees from GSK China were being investigated for suspected bribery and tax-related violations, more individuals involved in the case, including salespeople and doctors, are now under investigation. Full story